60 Day FRN

42656

Federal Register / Vol. 83, No. 164 / Thursday, August 23, 2018 / Notices

would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
RFA–CE19–001, Injury Control Research
Centers.
Dates: October 30, 2018 and
November 2, 2018
Time: 8:30 a.m.–5:00 p.m., EDT
Place: The Georgian Terrace, 659
Peachtree St. NE, Atlanta, GA, 30308
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Mikel L. Walters, M.A., Ph.D., Scientific
Review Official, NCIPC, CDC, 4770
Buford Highway NE, Mailstop F–63,
Atlanta, Georgia 30341, Telephone:
(404) 639–0913; Email: mwalters@
cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2018–18188 Filed 8–22–18; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Meeting of the Advisory Committee on
Immunization Practices
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:

In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
of the Advisory Committee on
Immunization Practices (ACIP). This
meeting is open to the public, limited
only by room seating. The meeting room
accommodates 400. Time will be
available for public comment.
DATES: The meeting will be held on
October 24, 2018, 8:30 a.m. to 5:15 p.m.,
EDT, and October 25, 2018, 8:30 a.m. to
4:00 p.m. EDT.
The public is welcome to submit
written comments in advance of the
meeting. Comments should be
submitted in writing by email to the
contact person listed in FOR FURTHER

daltland on DSKBBV9HB2PROD with NOTICES

SUMMARY:

VerDate Sep<11>2014

19:43 Aug 22, 2018

Jkt 244001

INFORMATION CONTACT. The deadline for
receipt is October 15, 2018.
ADDRESSES: CDC, 1600 Clifton Road NE,
Tom Harkin Global Communications
Center, Kent ‘Oz’ Nelson Auditorium,
Atlanta, GA 30329–4027.
The meeting will be webcast live via
the World Wide Web; for instructions
and more information on ACIP please
visit the ACIP website: http://
www.cdc.gov/vaccines/acip/index.html.
FOR FURTHER INFORMATION CONTACT:
Stephanie Thomas, ACIP Committee
Management Specialist, CDC, NCIRD,
telephone 404–639–8836, email ACIP@
cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The committee is charged
with advising the Director, CDC, on the
use of immunizing agents. In addition,
under 42 U.S.C. 1396s, the committee is
mandated to establish and periodically
review and, as appropriate, revise the
list of vaccines for administration to
vaccine-eligible children through the
Vaccines for Children (VFC) program,
along with schedules regarding dosing
interval, dosage, and contraindications
to administration of vaccines. Further,
under provisions of the Affordable Care
Act, section 2713 of the Public Health
Service Act, immunization
recommendations of the ACIP that have
been approved by the Director of the
Centers for Disease Control and
Prevention and appear on CDC
immunization schedules must be
covered by applicable health plans.
Matters to Be Considered: The agenda
will include discussions on child/
adolescent immunization schedule,
adult immunization schedule, human
papillomavirus vaccines, pneumococcal
vaccines, Japanese encephalitis
vaccines, zoster vaccine, Influenza
vaccines, general recommendations,
anthrax vaccine, hepatitis A vaccine,
Pertussis vaccine, and meningococcal
vaccines. A recommendation vote is
scheduled for child/adolescent
immunization schedule and adult
immunization schedule. Agenda items
are subject to change as priorities
dictate. For more information on the
meeting agenda visit https://
www.cdc.gov/vaccines/acip/meetings/
meetings-info.html.
Public Comment: Written comments
must include full name, address,
organizational affiliation, email address
of the speaker, topic being addressed
and specific comments. Written
comments must not exceed one singlespaced typed page with 1-inch margins
containing all items above. Only those
written comments received 10 business
days in advance of the meeting will be
included in the official record of the

PO 00000

Frm 00021

Fmt 4703

Sfmt 4703

meeting. Public comments made in
attendance must be no longer than 3
minutes and the person giving
comments must attend the public
comment session at the start time listed
on the agenda. Time for public
comments may start before the time
indicated on the agenda. The Director,
Management Analysis and Services
Office, has been delegated the authority
to sign Federal Register notices
pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2018–18184 Filed 8–22–18; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–18–18ATK; Docket No.CDC–2018–
0075]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Understanding multi-sectoral
collaboration for strengthening public
health capacities in Ethiopia. The goal
of this study is to explore multi-sectoral
collaboration in Ethiopia, in the context
of strengthening public health capacities
under the Global Health Security
Agenda.

SUMMARY:

CDC must receive written
comments on or before October 22,
2018.

DATES:

You may submit comments,
identified by Docket No. CDC–2018–
0075 by any of the following methods:

ADDRESSES:

E:\FR\FM\23AUN1.SGM

23AUN1

daltland on DSKBBV9HB2PROD with NOTICES

Federal Register / Vol. 83, No. 164 / Thursday, August 23, 2018 / Notices
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7118; Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other

VerDate Sep<11>2014

19:43 Aug 22, 2018

Jkt 244001

technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
Understanding multi-sectoral
collaboration for strengthening public
health capacities in Ethiopia—New—
Office of Public Health Preparedness
and Response (OPHPR), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Countries with poor public health
infrastructure are more vulnerable to
adverse health outcomes caused by
disease outbreaks, natural disasters, and
other public health events (Rodier,
2007). The 2013 Ebola outbreak in West
Africa highlighted the shortcomings of
infrastructure and preparedness plans in
the region, and prompted Ministries of
Health in affected countries to
reexamine capabilities and identify
approaches for strengthening them
(Heymann, 2015). More recently, the
spread of the Zika virus in 2015 through
more than twenty countries in the
Americas demonstrated that prioritizing
efforts to strengthen public health
systems and capacities is imperative to
mitigating the impact of public health
events and improving global health
security (Lucey, 2016).
Capacities refer to the abilities and
resources of countries to identify and
address problems, and carry out
functions for public health. Public
health emergency preparedness (PHEP)
related capacities focus acutely on the
resources and infrastructure required for
communities and countries to
effectively respond to incidents.
Zoonotic disease (ZD) related capacities
center on minimizing the spread of
diseases from animals to humans in
domestic, agricultural and wildlife
settings.
PHEP and ZD are regarded as crosscutting technical areas of public health,
spanning numerous fields of practice
and knowledge necessary to
successfully mitigate the impacts of
public health events. As a result, multisectoral collaboration—a cornerstone of
many public health initiatives and
programs—is a prominent feature of
efforts and plans to strengthen PHEP
and ZD capacities. While the
importance of multi-sectoral
collaboration for health strategies is
widely recognized by global health
experts and leaders, the evidence base
on demonstrated benefits and
advantages in public health capacity
building is limited. Some research has
been carried out to understand aspects

PO 00000

Frm 00022

Fmt 4703

Sfmt 4703

42657

of public health capacity strengthening
efforts and their impact on global health
security; however, it often focuses on
high-income countries, such as the
United States (U.S.). More research is
needed, particularly in low- and
middle-income country settings, to
understand how collaboration occurs
across sectors to implement efforts to
strengthen PHEP and ZD capacities and
systems, and to gain a deeper
understanding of the perspectives of
partners involved in the collaboration.
The purpose of the proposed research
is to explore how multi-sectoral
collaboration occurs for PHEP and ZD
related activities implemented under
the Global Health Security Agenda
(GHSA). The research will employ a
multiple-case study design in Ethiopia,
focusing on the GHSA technical areas of
PHEP and ZD as the cases. The study
seeks to understand the landscape of
stakeholders engaged in PHEP and ZD
related capacity development, and their
perspectives on one another’s roles and
contributions to efforts. This research
will also examine stakeholder
perceptions on barriers and facilitators
to collaboration under GHSA, overall
and in each technical area via in-depth
interviews. Finally, this study will
utilize an adapted questionnaire that
measures collaboration across five key
domains to foster dialogue between
partners on the strength of multisectoral collaboration in Ethiopia for
GHSA related ZD and PHEP activities.
Participants will be able to provide
feedback to these questionnaires
through a workshop. Research findings
will be compared across the two
technical areas to understand
similarities and differences in
stakeholder environments and partner
perspectives on collaboration under
GHSA; they can also be used to identify
opportunities to amplify successes and
overcome challenges for stakeholders to
collaborate across sectors—in Ethiopia
and other countries—to achieve ZD and
PHEP goals under GHSA. CDC will
disseminate information and findings
through presentations, publications, and
summary reports to stakeholders and
interested members of the public. This
research can enrich understanding
among stakeholders of one another’s
perspectives on collaborative efforts,
and encourage further dialogue on how
to best facilitate multi-sectoral
collaboration for broad global agendas
such as GHSA, and improved health
outcomes overall. CDC is requesting a
two year approval for this information
collection. Information collection
activities will begin approximately one
month after OMB approval.

E:\FR\FM\23AUN1.SGM

23AUN1

42658

Federal Register / Vol. 83, No. 164 / Thursday, August 23, 2018 / Notices

The total estimated cost to
respondents for their participation in
this proposed information collection is

$12,483.20. The total estimated burden
to respondents is 320 hours.

ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden per
response
(in hours)

Total
burden
(in hours)

Form name

Emergency Management Directors ...
Emergency Management Directors ...
Emergency Management Directors ...

In-depth interviews ...........................
Questionnaire ...................................
Questionnaire Feedback ..................

80
80
40

1
1
1

1
1
4

80
80
160

Total ...........................................

..........................................................

........................

........................

........................

320

Jeffrey M. Zirger,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2018–18179 Filed 8–22–18; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Solicitation of Nominations for
Appointment to the Board of Scientific
Counselors (BSC), Office of Infectious
Diseases (OID)
ACTION:

Notice.

The Centers for Disease
Control and Prevention (CDC) is seeking
nominations for membership on the
BSC, OID. The BSC, OID, consists of 17
experts in fields associated with the
issues addressed by CDC’s infectious
disease national centers (e.g., respiratory
diseases, antimicrobial resistance,
foodborne diseases, zoonotic and
vectorborne diseases, sexually
transmitted diseases) and specialties,
including clinical and public health
practice (including state and local
health departments), research and
diagnostics, bioinformatics, health
policy/communications, and industry.
Nominations are being sought for
individuals who have expertise and
qualifications necessary to contribute to
the accomplishments of the committee’s
objectives. Nominees will be selected
based on expertise in the fields of
infectious diseases and related
specialties. Federal employees will not
be considered for membership.
Members may be invited to serve for up
to four-year terms.
Selection of members is based on
candidates’ qualifications to contribute

SUMMARY:

daltland on DSKBBV9HB2PROD with NOTICES

Number of
responses per
respondent

Number of
respondents

Type of respondents

VerDate Sep<11>2014

19:43 Aug 22, 2018

Jkt 244001

to the accomplishment of BSC, OID,
objectives (www.cdc.gov/oid/BSC.html).
DATES: Nominations for membership on
the BSC, OID, must be received no later
than October 31, 2018. Packages
received after this time will not be
considered for the current membership
cycle.
ADDRESSES: All nominations should be
mailed to BSC, OID, MS H–24–12, 1600
Clifton Road, Atlanta, GA 30329, or
emailed (recommended) to SWiley@
cdc.gov.
FOR FURTHER INFORMATION CONTACT:
Sarah Wiley, M.P.H., Senior Advisor,
Office of Infectious Diseases, CDC, MS
H–24–12, 1600 Clifton Road, Atlanta,
GA 30329, 404–639–2100, SWiley@
cdc.gov.
SUPPLEMENTARY INFORMATION: The U.S.
Department of Health and Human
Services policy stipulates that
committee membership be balanced in
terms of points of view represented and
the committee’s function. Appointments
shall be made without discrimination
on the basis of age, race, ethnicity,
gender, sexual orientation, gender
identity, HIV status, disability, and
cultural, religious, or socioeconomic
status. Nominees must be U.S. citizens,
and cannot be full-time employees of
the U.S. Government. Current
participation on federal workgroups or
prior experience serving on a federal
advisory committee does not disqualify
a candidate; however, HHS policy is to
avoid excessive individual service on
advisory committees and multiple
committee memberships. Committee
members are Special Government
Employees (SGEs), requiring the filing
of financial disclosure reports at the
beginning and annually during their
terms. CDC reviews potential candidates
for BSC, OID membership each year,
and provides a slate of nominees for
consideration to the Secretary of HHS
for final selection. HHS notifies selected
candidates of their appointment near
the start of the term in October 2019, or

PO 00000

Frm 00023

Fmt 4703

Sfmt 9990

as soon as the HHS selection process is
completed. Note that the need for
different expertise varies from year to
year and a candidate who is not selected
in one year may be reconsidered in a
subsequent year. SGE Nominees must be
U.S. citizens, and cannot be full-time
employees of the U.S. Government.
Candidates should submit the following
items:
D Current curriculum vitae, including
complete contact information
(telephone numbers, mailing address,
email address).
D At least one letter of
recommendation from person(s) not
employed by the U.S. Department of
Health and Human Services.
(Candidates may submit letter(s) from
current HHS employees if they wish,
but at least one letter must be submitted
by a person not employed by an HHS
agency (e.g., CDC, NIH, FDA, etc.).
Nominations may be submitted by the
candidate him- or herself, or by the
person/organization recommending the
candidate.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both CDC and
the Agency for Toxic Substances and
Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2018–18187 Filed 8–22–18; 8:45 am]
BILLING CODE 4163–18–P

E:\FR\FM\23AUN1.SGM

23AUN1